Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Myron Levin

Concepts (855)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Herpes Zoster
106
2025
315
17.890
 Why?
Herpes Zoster Vaccine
66
2025
154
16.400
 Why?
Herpesvirus 3, Human
87
2025
336
12.020
 Why?
Antibodies, Viral
67
2026
686
4.980
 Why?
Chickenpox
24
2023
81
4.930
 Why?
Immunity, Cellular
36
2024
273
4.480
 Why?
Chickenpox Vaccine
27
2023
75
3.730
 Why?
Influenza Vaccines
18
2024
528
2.830
 Why?
Vaccines, Attenuated
32
2024
130
2.620
 Why?
HIV Infections
39
2026
3084
2.420
 Why?
Neuralgia, Postherpetic
18
2019
39
2.350
 Why?
Immunocompromised Host
13
2019
202
2.330
 Why?
Antiviral Agents
28
2022
749
2.210
 Why?
Adjuvants, Immunologic
17
2023
246
2.050
 Why?
Simplexvirus
24
2016
82
2.030
 Why?
Acyclovir
27
2016
96
1.980
 Why?
Herpes Simplex
17
2016
97
1.820
 Why?
Vaccination
33
2023
1424
1.780
 Why?
DNA, Viral
24
2018
361
1.670
 Why?
Trypanosoma cruzi
13
2007
40
1.630
 Why?
Papillomavirus Vaccines
13
2018
298
1.490
 Why?
Viral Envelope Proteins
6
2021
99
1.410
 Why?
Herpesvirus 1, Human
10
2016
84
1.390
 Why?
Influenza, Human
13
2024
615
1.350
 Why?
Pregnancy Complications, Infectious
16
2020
424
1.350
 Why?
Vaccines, Synthetic
16
2025
140
1.350
 Why?
Humans
296
2026
145077
1.310
 Why?
T-Lymphocytes
20
2019
2045
1.300
 Why?
Antiretroviral Therapy, Highly Active
13
2017
278
1.290
 Why?
Aged
92
2024
25862
1.240
 Why?
Immunologic Memory
12
2019
376
1.230
 Why?
Aged, 80 and over
47
2022
8200
1.220
 Why?
Immunization, Secondary
13
2017
91
1.220
 Why?
CD4-Positive T-Lymphocytes
13
2023
1147
1.160
 Why?
Antibodies, Protozoan
5
2007
41
1.110
 Why?
Papillomavirus Infections
9
2018
354
1.110
 Why?
Middle Aged
102
2026
36003
1.040
 Why?
Ribosomal Proteins
6
2006
93
1.030
 Why?
Double-Blind Method
33
2026
2032
1.000
 Why?
Chagas Disease
8
2007
44
1.000
 Why?
Pneumococcal Vaccines
4
2026
129
0.990
 Why?
Female
158
2026
78355
0.970
 Why?
Protozoan Proteins
6
2006
93
0.970
 Why?
Male
141
2026
72317
0.930
 Why?
T-Lymphocyte Subsets
6
2019
422
0.930
 Why?
Vaccines, Inactivated
9
2023
70
0.870
 Why?
Receptors, Adrenergic, beta-1
4
2007
23
0.860
 Why?
Viral Vaccines
12
2014
108
0.860
 Why?
Antibodies, Neutralizing
13
2023
347
0.850
 Why?
Incidence
22
2023
2870
0.830
 Why?
Herpesvirus 2, Human
6
2014
28
0.830
 Why?
Virus Latency
4
2014
90
0.790
 Why?
Interferon-gamma
18
2022
792
0.790
 Why?
Immune Sera
4
2020
77
0.780
 Why?
Respiratory Syncytial Virus, Human
3
2019
82
0.770
 Why?
CD8-Positive T-Lymphocytes
5
2018
949
0.750
 Why?
B-Lymphocytes
9
2021
890
0.750
 Why?
Injections, Intramuscular
5
2022
137
0.750
 Why?
Enzyme-Linked Immunosorbent Assay
22
2021
858
0.750
 Why?
Influenza A Virus, H1N1 Subtype
6
2017
157
0.720
 Why?
Age Factors
17
2021
3315
0.710
 Why?
Respiratory Syncytial Virus Vaccines
2
2019
39
0.700
 Why?
Rotavirus Infections
3
2017
35
0.700
 Why?
Drug Resistance, Viral
7
2009
119
0.690
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
6
2017
13
0.690
 Why?
Influenza B virus
6
2012
47
0.660
 Why?
Anti-Retroviral Agents
5
2018
241
0.650
 Why?
Vaccination Coverage
2
2018
102
0.630
 Why?
Rotavirus Vaccines
2
2017
37
0.630
 Why?
Adenovirus Infections, Human
4
2015
15
0.610
 Why?
Infectious Disease Transmission, Vertical
7
2020
186
0.610
 Why?
Adult
77
2026
40538
0.590
 Why?
Down Syndrome
2
2023
535
0.590
 Why?
Th1 Cells
3
2018
142
0.590
 Why?
Polymerase Chain Reaction
13
2019
1058
0.580
 Why?
Clinical Trials as Topic
15
2019
1056
0.580
 Why?
Child, Preschool
43
2026
11749
0.570
 Why?
Insurance Claim Review
1
2019
83
0.570
 Why?
HIV
4
2010
248
0.570
 Why?
AIDS-Related Opportunistic Infections
4
2015
130
0.560
 Why?
Alphapapillomavirus
4
2016
36
0.560
 Why?
Influenza A Virus, H3N2 Subtype
4
2017
51
0.560
 Why?
Cytomegalovirus Infections
4
2015
207
0.560
 Why?
CD4 Lymphocyte Count
14
2017
276
0.550
 Why?
Antibody Formation
8
2023
294
0.550
 Why?
Immunoglobulin G
11
2021
899
0.530
 Why?
Child
60
2026
22649
0.530
 Why?
Dose-Response Relationship, Immunologic
3
2016
77
0.530
 Why?
Infant
31
2023
9994
0.530
 Why?
Virus Shedding
6
2017
48
0.530
 Why?
Health Expenditures
1
2019
192
0.510
 Why?
Pneumonia
1
2023
642
0.510
 Why?
Adolescent
54
2026
22453
0.510
 Why?
Pain
6
2022
782
0.500
 Why?
Herpesviridae Infections
4
2015
149
0.500
 Why?
Cytosine
3
2015
49
0.500
 Why?
Anti-HIV Agents
6
2015
870
0.500
 Why?
Interleukin-2
7
2022
447
0.500
 Why?
Infant, Premature
5
2020
612
0.490
 Why?
Antigens, Viral
21
2017
183
0.480
 Why?
Organophosphonates
2
2015
96
0.480
 Why?
Cytomegalovirus
7
2006
168
0.470
 Why?
Injections, Subcutaneous
1
2016
167
0.470
 Why?
Enzyme-Linked Immunospot Assay
4
2018
37
0.460
 Why?
Guanine
14
2006
86
0.460
 Why?
Follow-Up Studies
22
2019
5367
0.450
 Why?
Refrigeration
2
2018
12
0.450
 Why?
Immunization
5
2014
375
0.440
 Why?
Polyomavirus Infections
1
2015
30
0.440
 Why?
Health Care Costs
1
2018
418
0.440
 Why?
Immunity, Humoral
3
2021
119
0.430
 Why?
Viral Load
12
2018
517
0.430
 Why?
Uterine Cervical Neoplasms
5
2016
275
0.430
 Why?
Skin Diseases
1
2016
151
0.420
 Why?
Oropharynx
1
2014
47
0.420
 Why?
Herpes Genitalis
7
2014
18
0.420
 Why?
Blood
1
2014
112
0.420
 Why?
Drug Combinations
4
2023
381
0.400
 Why?
Infant, Newborn
28
2023
6411
0.400
 Why?
Immunogenicity, Vaccine
4
2022
36
0.390
 Why?
Monocytes
8
2025
544
0.390
 Why?
Vaccines
3
2018
389
0.390
 Why?
T-Lymphocytes, Regulatory
1
2016
393
0.390
 Why?
Herpes Labialis
3
2013
8
0.380
 Why?
Placebos
8
2017
192
0.380
 Why?
Trigeminal Ganglion
2
2003
26
0.380
 Why?
Time Factors
20
2021
7120
0.380
 Why?
Post-Exposure Prophylaxis
2
2023
13
0.360
 Why?
Sensory Receptor Cells
1
2012
101
0.350
 Why?
Aging
10
2017
1981
0.350
 Why?
United States
18
2026
15746
0.350
 Why?
RNA, Viral
21
2018
693
0.350
 Why?
Young Adult
24
2023
14082
0.350
 Why?
Retrospective Studies
16
2023
16954
0.350
 Why?
Communicable Diseases
1
2014
163
0.350
 Why?
Randomized Controlled Trials as Topic
8
2021
1707
0.350
 Why?
Human papillomavirus 18
5
2018
14
0.320
 Why?
Quality of Life
7
2021
3178
0.320
 Why?
Human papillomavirus 16
5
2018
31
0.310
 Why?
Glycoproteins
2
2023
357
0.310
 Why?
Databases, Factual
4
2019
1474
0.310
 Why?
Pregnancy
20
2020
7200
0.310
 Why?
Animals
42
2021
38352
0.300
 Why?
Induced Pluripotent Stem Cells
1
2012
276
0.300
 Why?
Chagas Cardiomyopathy
4
2007
27
0.300
 Why?
Cost-Benefit Analysis
4
2024
621
0.300
 Why?
Poverty
1
2013
525
0.300
 Why?
Frail Elderly
2
2020
133
0.290
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2009
19
0.290
 Why?
Vaccines, Subunit
5
2021
53
0.290
 Why?
Risk Factors
20
2023
10700
0.290
 Why?
Treatment Outcome
19
2016
11612
0.280
 Why?
Epitopes
4
2005
491
0.270
 Why?
Varicella Zoster Virus Infection
2
2018
27
0.270
 Why?
Meningitis, Viral
3
1997
20
0.260
 Why?
Activities of Daily Living
3
2021
440
0.260
 Why?
Meningitis
1
2008
80
0.260
 Why?
Hemagglutination Inhibition Tests
7
2017
38
0.260
 Why?
Seasons
3
2023
557
0.260
 Why?
Autoantibodies
3
2007
1498
0.260
 Why?
Research Design
2
2013
1131
0.250
 Why?
Viral Plaque Assay
8
2012
32
0.250
 Why?
Antibodies, Monoclonal
3
2023
1525
0.250
 Why?
Cytokines
7
2018
2101
0.250
 Why?
Recurrence
14
2019
1130
0.250
 Why?
Cells, Cultured
19
2012
4178
0.250
 Why?
Viremia
5
2018
158
0.250
 Why?
Prospective Studies
25
2019
7982
0.240
 Why?
Neurons
6
2003
1645
0.240
 Why?
Immunocompetence
4
2019
47
0.230
 Why?
Respiratory Syncytial Virus Infections
3
2017
136
0.230
 Why?
Nucleic Acid Hybridization
11
2006
189
0.230
 Why?
Drug-Related Side Effects and Adverse Reactions
4
2017
258
0.220
 Why?
Neoplasms
3
2016
2932
0.220
 Why?
Virus Replication
12
2018
538
0.220
 Why?
Sleep Wake Disorders
4
2013
312
0.220
 Why?
Nucleosides
1
2004
25
0.220
 Why?
Cross Reactions
6
2014
135
0.220
 Why?
Cell Count
2
2005
324
0.220
 Why?
Intestines
2
2018
358
0.220
 Why?
Vaccine Potency
3
2019
6
0.220
 Why?
Severity of Illness Index
14
2015
2944
0.220
 Why?
Transforming Growth Factor beta1
1
2025
180
0.210
 Why?
Viral Proteins
5
2018
366
0.210
 Why?
Molecular Sequence Data
9
2006
2914
0.210
 Why?
Influenza A virus
5
2012
112
0.210
 Why?
Health Resources
2
2019
131
0.210
 Why?
Nonlinear Dynamics
1
2005
95
0.210
 Why?
Interferons
9
1982
193
0.200
 Why?
Phosphoproteins
1
2006
348
0.200
 Why?
Herpesvirus 4, Human
3
2014
173
0.200
 Why?
Cholecalciferol
1
2024
61
0.200
 Why?
Neuralgia
4
2010
144
0.200
 Why?
Genetic Variation
1
2008
992
0.200
 Why?
Immunoassay
2
2017
113
0.200
 Why?
Antibody Affinity
2
2021
60
0.190
 Why?
Long-Term Care
1
2024
116
0.190
 Why?
Cricetinae
6
2007
301
0.190
 Why?
Enterovirus Infections
5
1995
174
0.190
 Why?
Transforming Growth Factor beta
1
2025
481
0.190
 Why?
Encephalitis
2
1995
139
0.190
 Why?
Ganglia, Spinal
2
1993
88
0.190
 Why?
Developing Countries
2
2016
315
0.190
 Why?
CHO Cells
3
2007
169
0.180
 Why?
Pain Measurement
8
2019
558
0.180
 Why?
Lymphocyte Activation
13
2015
1143
0.180
 Why?
Antibodies, Bacterial
4
2026
147
0.180
 Why?
Recombinant Proteins
4
2018
1358
0.180
 Why?
Papillomaviridae
3
2011
121
0.180
 Why?
Lymphocytosis
1
2021
11
0.180
 Why?
Virus Activation
4
2010
95
0.180
 Why?
Longitudinal Studies
8
2018
2977
0.170
 Why?
Immunosenescence
1
2021
5
0.170
 Why?
Cell Separation
1
2002
312
0.170
 Why?
Mice
12
2021
18562
0.170
 Why?
Herpes Simplex Virus Vaccines
2
2012
4
0.170
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
78
0.170
 Why?
Genes, Protozoan
1
2000
13
0.170
 Why?
Virology
1
2001
36
0.170
 Why?
Fluorescent Antibody Technique
6
2016
376
0.160
 Why?
Intermediate Filament Proteins
1
2000
57
0.160
 Why?
Case-Control Studies
5
2018
3635
0.160
 Why?
Fetal Diseases
4
1991
191
0.160
 Why?
Cell Line
16
2018
2911
0.160
 Why?
RNA Helicases
1
2000
32
0.160
 Why?
Amino Acid Sequence
5
2006
2149
0.160
 Why?
Vitamin D
1
2024
402
0.160
 Why?
Fibroblasts
10
2018
1042
0.160
 Why?
Immunoglobulin A
3
2017
218
0.160
 Why?
Terminal Repeat Sequences
1
2000
18
0.160
 Why?
Health Services for the Aged
1
2001
72
0.160
 Why?
Short Interspersed Nucleotide Elements
1
2000
11
0.160
 Why?
Enterovirus
3
1995
83
0.160
 Why?
Laboratories
1
2001
111
0.160
 Why?
Feces
3
2017
509
0.160
 Why?
HIV-1
5
2018
907
0.160
 Why?
Acquired Immunodeficiency Syndrome
2
1993
230
0.160
 Why?
Antidepressive Agents
2
2013
240
0.150
 Why?
Cohort Studies
10
2022
5930
0.150
 Why?
Carrier Proteins
2
2001
750
0.150
 Why?
Immunoenzyme Techniques
3
2006
201
0.150
 Why?
Retroelements
1
2000
52
0.150
 Why?
Epitope Mapping
3
2005
65
0.150
 Why?
Immunization, Passive
4
1994
87
0.150
 Why?
Leukocytes, Mononuclear
5
2010
580
0.150
 Why?
Dietary Supplements
1
2024
577
0.150
 Why?
Base Sequence
10
2007
2188
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2026
990
0.150
 Why?
Myocytes, Cardiac
1
2004
550
0.150
 Why?
Immunization Schedule
3
2016
187
0.150
 Why?
Pneumococcal Infections
2
2013
104
0.150
 Why?
Hemophilia A
2
1993
146
0.150
 Why?
Delivery of Health Care, Integrated
1
2022
301
0.150
 Why?
Myocardium
3
2001
949
0.140
 Why?
Heart Transplantation
2
2007
734
0.140
 Why?
Cholera Toxin
1
2018
30
0.140
 Why?
Liver Transplantation
1
2006
795
0.140
 Why?
Autophagosomes
1
2018
20
0.140
 Why?
Infant, Premature, Diseases
3
1995
111
0.140
 Why?
Microbial Sensitivity Tests
8
2005
374
0.140
 Why?
Age Distribution
3
2016
396
0.140
 Why?
Sex Distribution
3
2016
381
0.140
 Why?
Killer Cells, Natural
2
2025
475
0.140
 Why?
Fatty Acid-Binding Proteins
1
2018
79
0.140
 Why?
Lymphocytes
8
1998
396
0.140
 Why?
Drug Therapy, Combination
4
2016
1035
0.140
 Why?
Regression Analysis
2
2019
1003
0.130
 Why?
Viral Fusion Proteins
1
2017
21
0.130
 Why?
Simian virus 40
11
1977
24
0.130
 Why?
Genes, Viral
2
2006
92
0.130
 Why?
Lysosomes
1
2018
132
0.130
 Why?
Immune Evasion
1
2018
67
0.130
 Why?
Multivariate Analysis
2
2018
1512
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
78
0.130
 Why?
Clinical Trials, Phase I as Topic
1
2017
52
0.130
 Why?
Protein Subunits
1
2018
230
0.130
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
12
0.130
 Why?
Hepatitis B Vaccines
2
2026
42
0.130
 Why?
Disease Transmission, Infectious
1
2018
68
0.130
 Why?
Cell Division
5
2003
780
0.130
 Why?
Cryopreservation
1
2018
110
0.130
 Why?
Observational Studies as Topic
1
2017
128
0.130
 Why?
Cost of Illness
5
2014
321
0.130
 Why?
Body Mass Index
1
2026
2452
0.130
 Why?
Models, Biological
1
2005
1838
0.130
 Why?
Infectious Mononucleosis
2
1991
10
0.130
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
81
0.130
 Why?
Receptors, Muscarinic
1
1996
20
0.130
 Why?
Receptors, Adrenergic, beta-2
1
1996
35
0.120
 Why?
Africa
1
2017
114
0.120
 Why?
Infusions, Intravenous
2
2016
429
0.120
 Why?
Foscarnet
3
2003
20
0.120
 Why?
Triatoma
2
2006
7
0.120
 Why?
Nelfinavir
1
2016
8
0.120
 Why?
Depression
3
2013
1538
0.120
 Why?
Latex Fixation Tests
1
1996
4
0.120
 Why?
Erythema
1
2016
28
0.120
 Why?
Comorbidity
3
2019
1640
0.120
 Why?
Lopinavir
1
2016
30
0.120
 Why?
Ribavirin
2
1994
71
0.120
 Why?
Atazanavir Sulfate
1
2016
42
0.120
 Why?
Insect Vectors
2
2006
39
0.120
 Why?
Frailty
1
2019
193
0.120
 Why?
Peptide Fragments
3
2007
707
0.120
 Why?
Autophagy
1
2018
288
0.120
 Why?
HIV Protease Inhibitors
1
2016
69
0.120
 Why?
Ritonavir
1
2016
74
0.120
 Why?
Bone Marrow Transplantation
3
1990
295
0.110
 Why?
Dipeptides
1
2015
57
0.110
 Why?
Lymphocyte Subsets
1
2015
87
0.110
 Why?
Genotype
3
2008
1842
0.110
 Why?
Drug Administration Schedule
3
2026
779
0.110
 Why?
BK Virus
1
2015
17
0.110
 Why?
Brain Stem
1
1995
96
0.110
 Why?
Host-Pathogen Interactions
1
2018
374
0.110
 Why?
Chronic Disease
6
2019
1833
0.110
 Why?
Hospitalization
2
2023
2361
0.110
 Why?
Hematopoietic Stem Cell Transplantation
2
2015
681
0.110
 Why?
Data Interpretation, Statistical
3
2019
371
0.110
 Why?
Guatemala
1
2016
345
0.110
 Why?
Programmed Cell Death 1 Receptor
1
2017
273
0.110
 Why?
Propylene Glycols
1
2015
27
0.110
 Why?
TOR Serine-Threonine Kinases
1
2018
453
0.110
 Why?
Medication Reconciliation
1
2015
31
0.110
 Why?
Global Health
1
2018
395
0.110
 Why?
Sphingosine
1
2015
45
0.110
 Why?
Reproducibility of Results
5
2013
3414
0.110
 Why?
Infant, Newborn, Diseases
1
2016
114
0.110
 Why?
Transfusion Reaction
1
1995
62
0.110
 Why?
COS Cells
2
2007
181
0.110
 Why?
Survival Rate
3
2016
2052
0.110
 Why?
Maus Elberfeld virus
2
1991
5
0.110
 Why?
Respiratory Syncytial Viruses
4
1993
58
0.110
 Why?
Maternal-Fetal Exchange
3
1995
169
0.110
 Why?
Immunity, Mucosal
2
2012
99
0.110
 Why?
Chlamydia trachomatis
2
1991
51
0.110
 Why?
Species Specificity
3
2006
576
0.110
 Why?
Histocompatibility Antigens Class I
1
1996
208
0.100
 Why?
Hemagglutinins, Viral
1
1994
7
0.100
 Why?
Clinical Trials, Phase III as Topic
3
2021
118
0.100
 Why?
Laryngeal Diseases
1
1994
32
0.100
 Why?
DNA-Directed DNA Polymerase
2
1992
48
0.100
 Why?
Rats
4
2006
5633
0.100
 Why?
Immunoglobulins, Intravenous
5
1995
128
0.100
 Why?
Lymphoma
1
2015
236
0.100
 Why?
Zidovudine
2
2015
77
0.100
 Why?
Autoantigens
1
1996
432
0.100
 Why?
Lamivudine
2
2015
64
0.100
 Why?
Analgesics
3
2010
230
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
28
0.100
 Why?
Needs Assessment
1
2016
403
0.100
 Why?
Cross-Over Studies
2
2013
601
0.100
 Why?
Placenta
2
1991
780
0.100
 Why?
Ethics, Research
1
2013
31
0.100
 Why?
Anti-Inflammatory Agents
3
2013
483
0.100
 Why?
Practice Guidelines as Topic
2
2017
1534
0.100
 Why?
Research Subjects
1
2013
43
0.100
 Why?
Mice, Inbred BALB C
3
2006
1272
0.100
 Why?
RNA Probes
2
1991
14
0.100
 Why?
Health Status
2
2010
825
0.090
 Why?
Epitopes, T-Lymphocyte
1
2014
186
0.090
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1996
293
0.090
 Why?
Dose-Response Relationship, Drug
4
2026
2039
0.090
 Why?
Risk Assessment
4
2016
3582
0.090
 Why?
Measles Vaccine
1
2012
18
0.090
 Why?
Picornaviridae Infections
2
1990
50
0.090
 Why?
Gene Expression Regulation, Viral
1
2012
99
0.090
 Why?
Autoimmune Diseases
1
1996
464
0.090
 Why?
Human papillomavirus 31
1
2011
1
0.090
 Why?
Drug Resistance, Microbial
4
2001
70
0.090
 Why?
Immunosuppressive Agents
3
2015
844
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
Colorado
4
2018
4608
0.090
 Why?
Meningitis, Aseptic
1
1991
13
0.090
 Why?
Flow Cytometry
5
2017
1193
0.090
 Why?
T-Lymphocytes, Cytotoxic
2
2011
179
0.090
 Why?
Indoles
1
2015
494
0.090
 Why?
Efficiency
1
2012
103
0.090
 Why?
Linear Models
2
2010
861
0.090
 Why?
Chorioamnionitis
1
1991
45
0.080
 Why?
Insurance, Health
1
2014
297
0.080
 Why?
Cytotoxicity Tests, Immunologic
2
1996
37
0.080
 Why?
Gastroenteritis
2
1989
62
0.080
 Why?
Mutation
5
2009
4132
0.080
 Why?
Neurogenesis
1
2012
157
0.080
 Why?
Macrophages
3
2005
1533
0.080
 Why?
Neural Stem Cells
1
2012
166
0.080
 Why?
Sequence Alignment
2
2008
362
0.080
 Why?
Drug Design
1
2012
175
0.080
 Why?
Adjuvants, Pharmaceutic
2
2022
15
0.080
 Why?
Epidemiological Monitoring
3
2018
70
0.080
 Why?
Cervix Uteri
1
2010
52
0.080
 Why?
Exanthema
1
2011
84
0.080
 Why?
Serum
1
2010
58
0.080
 Why?
Sensitivity and Specificity
3
2009
1989
0.080
 Why?
Adenoviridae
9
2005
204
0.080
 Why?
Herpesviridae
2
1981
22
0.080
 Why?
Electrocardiography
2
2005
639
0.080
 Why?
Antidepressive Agents, Tricyclic
1
2010
31
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Heart Rate
2
2006
848
0.080
 Why?
Antigen-Presenting Cells
5
2010
163
0.080
 Why?
Immunoglobulin M
1
1991
288
0.080
 Why?
Enterovirus B, Human
2
1988
25
0.080
 Why?
Health Services Accessibility
1
2018
1092
0.080
 Why?
Dermatomyositis
1
1989
24
0.080
 Why?
Respiratory Tract Infections
1
1994
397
0.080
 Why?
Poliovirus
2
2001
73
0.080
 Why?
DNA, Kinetoplast
2
2006
2
0.080
 Why?
Medicaid
1
2014
459
0.080
 Why?
Receptors, Virus
2
2006
97
0.070
 Why?
Placenta Diseases
1
1989
19
0.070
 Why?
Protozoan Infections
1
1989
10
0.070
 Why?
DNA Primers
2
2009
517
0.070
 Why?
Drug Stability
1
2009
165
0.070
 Why?
Pilot Projects
1
2015
1873
0.070
 Why?
Thymidine Kinase
4
2001
17
0.070
 Why?
Surveys and Questionnaires
7
2021
6069
0.070
 Why?
Skin Diseases, Viral
1
2008
6
0.070
 Why?
Oligonucleotide Probes
1
1988
50
0.070
 Why?
Geriatrics
1
2010
96
0.070
 Why?
Immunologic Deficiency Syndromes
2
1986
69
0.070
 Why?
Gene Expression
2
2006
1518
0.070
 Why?
Vagina
1
2010
202
0.070
 Why?
Muscles
1
1989
334
0.070
 Why?
Hydrocortisone
1
2010
308
0.070
 Why?
Geriatric Assessment
1
2010
231
0.070
 Why?
In Vitro Techniques
6
2003
1057
0.070
 Why?
Kinetics
2
2010
1627
0.070
 Why?
Administration, Intranasal
1
2008
95
0.070
 Why?
Poisson Distribution
2
2005
76
0.070
 Why?
Postoperative Complications
2
2000
2939
0.070
 Why?
Interferon Type I
1
1989
146
0.070
 Why?
Picornaviridae
1
1988
18
0.070
 Why?
Lipid A
2
2018
28
0.070
 Why?
Enterocolitis, Pseudomembranous
1
1988
28
0.070
 Why?
Pertussis Vaccine
1
2007
24
0.070
 Why?
Anticonvulsants
1
2010
232
0.070
 Why?
Evidence-Based Practice
1
2010
235
0.070
 Why?
Immunosorbent Techniques
1
2007
18
0.070
 Why?
Quality-Adjusted Life Years
1
2007
116
0.060
 Why?
Data Collection
1
2010
638
0.060
 Why?
Spinal Cord
2
2001
381
0.060
 Why?
Prevalence
4
2018
2836
0.060
 Why?
Cricetulus
1
2007
116
0.060
 Why?
Receptor, IGF Type 2
1
2006
5
0.060
 Why?
Acute Kidney Injury
1
2015
851
0.060
 Why?
Inhibitory Concentration 50
1
2006
93
0.060
 Why?
Vero Cells
1
2006
87
0.060
 Why?
Trypanosomatina
1
2006
1
0.060
 Why?
Opportunistic Infections
3
1993
44
0.060
 Why?
Research
1
2010
428
0.060
 Why?
Immunoglobulin Fragments
1
2006
11
0.060
 Why?
Public Health
1
2012
564
0.060
 Why?
Animal Diseases
1
2006
8
0.060
 Why?
Neutralization Tests
5
2012
80
0.060
 Why?
Pregnancy Outcome
1
2010
476
0.060
 Why?
NIH 3T3 Cells
1
2006
151
0.060
 Why?
Veterans
1
2018
1601
0.060
 Why?
Administration, Topical
4
2013
153
0.060
 Why?
Cyclic AMP
1
2007
209
0.060
 Why?
Immunoglobulin Variable Region
1
2006
80
0.060
 Why?
Random Allocation
6
1992
366
0.060
 Why?
Meningococcal Vaccines
1
2006
58
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
1968
0.060
 Why?
Trees
1
2006
68
0.060
 Why?
Kaplan-Meier Estimate
3
2016
961
0.060
 Why?
Hepatitis A Vaccines
1
2026
20
0.060
 Why?
Nasopharyngeal Diseases
1
1985
5
0.060
 Why?
Hybridization, Genetic
9
1974
74
0.060
 Why?
Pneumonia, Viral
2
1990
382
0.060
 Why?
Logistic Models
2
2010
2101
0.060
 Why?
Motor Activity
1
2010
723
0.060
 Why?
Endocytosis
1
2006
171
0.060
 Why?
Bone Marrow
2
1984
305
0.060
 Why?
Sequence Analysis, DNA
3
2007
829
0.060
 Why?
GB virus C
1
2005
1
0.060
 Why?
Flaviviridae Infections
1
2005
2
0.060
 Why?
Uterine Cervical Dysplasia
2
2016
30
0.060
 Why?
Hepatitis, Viral, Human
1
2005
20
0.060
 Why?
Proportional Hazards Models
1
2009
1308
0.060
 Why?
HLA Antigens
3
1987
227
0.060
 Why?
Predictive Value of Tests
3
2010
2105
0.060
 Why?
Antineoplastic Agents
2
2016
2225
0.060
 Why?
Hydrogen-Ion Concentration
1
2006
564
0.060
 Why?
Normal Distribution
1
2005
22
0.060
 Why?
Evaluation Studies as Topic
3
1996
169
0.060
 Why?
Cell Differentiation
1
2012
2064
0.050
 Why?
Organ Transplantation
1
2008
247
0.050
 Why?
Blotting, Western
3
2015
1207
0.050
 Why?
Conservation of Natural Resources
1
2006
132
0.050
 Why?
Transfection
1
2007
953
0.050
 Why?
Open Reading Frames
2
2007
133
0.050
 Why?
Autopsy
2
2001
93
0.050
 Why?
Mammals
1
2006
292
0.050
 Why?
Neurons, Afferent
1
2005
102
0.050
 Why?
Disease Outbreaks
1
1988
423
0.050
 Why?
Risk
3
2016
905
0.050
 Why?
Receptors, Cholinergic
1
2004
41
0.050
 Why?
Macaca radiata
2
2001
15
0.050
 Why?
Cell Culture Techniques
1
2006
380
0.050
 Why?
Cell Adhesion Molecules
1
2005
178
0.050
 Why?
Receptors, Adrenergic, beta
1
2004
61
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2003
65
0.050
 Why?
Mental Health
1
2010
783
0.050
 Why?
Sex Factors
2
2003
2094
0.050
 Why?
Demography
2
2018
290
0.050
 Why?
Abdominal Neoplasms
1
2003
47
0.050
 Why?
Receptors, Cell Surface
1
2005
380
0.050
 Why?
Down-Regulation
1
2025
641
0.050
 Why?
2-Aminopurine
2
2007
8
0.050
 Why?
RNA
2
1988
942
0.050
 Why?
Pre-Exposure Prophylaxis
1
2026
244
0.050
 Why?
Membrane Glycoproteins
1
2005
500
0.050
 Why?
Polymorphism, Single Nucleotide
2
2009
2187
0.050
 Why?
Multicenter Studies as Topic
2
2001
401
0.050
 Why?
Adaptive Immunity
2
2017
171
0.050
 Why?
Biopsy
2
2000
1071
0.050
 Why?
Argentina
3
2006
29
0.050
 Why?
Poliomyelitis
2
2001
35
0.050
 Why?
Dendritic Cells
1
2025
506
0.050
 Why?
Forecasting
3
2010
391
0.040
 Why?
Maltose-Binding Proteins
1
2001
13
0.040
 Why?
Neuroblastoma
1
2003
173
0.040
 Why?
Hepatitis C
1
2004
252
0.040
 Why?
Glutathione Transferase
1
2001
99
0.040
 Why?
Cell Nucleus
3
1991
620
0.040
 Why?
Respirovirus Infections
2
1991
14
0.040
 Why?
Spondylarthropathies
1
2021
5
0.040
 Why?
Poliovirus Vaccine, Oral
1
2001
25
0.040
 Why?
Interspersed Repetitive Sequences
1
2000
5
0.040
 Why?
Peripheral Nerves
1
2001
72
0.040
 Why?
Blotting, Southern
1
2000
85
0.040
 Why?
Expressed Sequence Tags
1
2000
44
0.040
 Why?
Fatal Outcome
1
2001
307
0.040
 Why?
Endocardium
1
2000
31
0.040
 Why?
Secondary Prevention
2
2013
238
0.040
 Why?
Mutagenesis
1
2001
193
0.040
 Why?
Alanine
1
2001
169
0.040
 Why?
Cloning, Molecular
1
2001
543
0.040
 Why?
Blotting, Northern
1
2000
204
0.040
 Why?
Phosphorylation
2
2002
1763
0.040
 Why?
Genome, Viral
1
2002
223
0.040
 Why?
Virion
1
2001
115
0.040
 Why?
Sex Characteristics
2
2017
791
0.040
 Why?
DNA, Protozoan
1
2000
32
0.040
 Why?
Consensus Sequence
1
2000
75
0.040
 Why?
Amino Acid Motifs
1
2000
225
0.040
 Why?
DEAD-box RNA Helicases
1
2000
90
0.040
 Why?
Psoriasis
1
2021
110
0.040
 Why?
Canada
2
2012
426
0.040
 Why?
Amniotic Fluid
3
1991
79
0.040
 Why?
Chromosome Mapping
1
2000
513
0.040
 Why?
Immunity, Innate
1
2025
856
0.040
 Why?
Autoimmunity
1
2005
928
0.040
 Why?
Transcription, Genetic
5
2000
1507
0.040
 Why?
Sequence Homology, Amino Acid
1
2000
392
0.040
 Why?
Enterotoxins
2
1994
89
0.040
 Why?
Sleep
1
2006
909
0.040
 Why?
Recombinant Fusion Proteins
1
2001
685
0.040
 Why?
Rats, Sprague-Dawley
1
2004
2538
0.040
 Why?
Saponins
1
2018
11
0.030
 Why?
Hematopoietic Stem Cells
1
1982
422
0.030
 Why?
Seroconversion
1
2018
50
0.030
 Why?
Saliva
2
2010
251
0.030
 Why?
Haptoglobins
1
2018
66
0.030
 Why?
Encephalitis, Viral
1
1998
45
0.030
 Why?
Protein Precursors
1
2018
136
0.030
 Why?
Drug Compounding
1
2018
108
0.030
 Why?
Immunologic Techniques
2
1994
39
0.030
 Why?
Celiac Disease
1
2021
308
0.030
 Why?
Glucosides
1
2017
56
0.030
 Why?
Inositol Phosphates
1
2017
21
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Botswana
1
2017
9
0.030
 Why?
Cell Transformation, Neoplastic
5
1977
342
0.030
 Why?
International Cooperation
1
2018
197
0.030
 Why?
Health Surveys
1
2019
513
0.030
 Why?
Internationality
1
2018
154
0.030
 Why?
Graft Rejection
1
2000
538
0.030
 Why?
Chemotaxis
1
2017
123
0.030
 Why?
Zambia
1
2017
56
0.030
 Why?
Zimbabwe
1
2017
74
0.030
 Why?
Tanzania
1
2017
62
0.030
 Why?
Bisoprolol
1
1996
2
0.030
 Why?
Antigens, Bacterial
1
2017
125
0.030
 Why?
Plasma
1
2018
227
0.030
 Why?
Patient Safety
1
2020
339
0.030
 Why?
Propanolamines
1
1996
40
0.030
 Why?
Recovery of Function
1
2021
704
0.030
 Why?
Cerebrospinal Fluid
2
1993
92
0.030
 Why?
Acute Disease
2
2011
1006
0.030
 Why?
Leukemia, Lymphoid
2
1986
27
0.030
 Why?
Immune Tolerance
4
1998
384
0.030
 Why?
Biomarkers
2
2018
4283
0.030
 Why?
Sinusitis
1
1999
239
0.030
 Why?
False Negative Reactions
1
1996
63
0.030
 Why?
Public Health Surveillance
1
2016
83
0.030
 Why?
False Positive Reactions
1
1996
126
0.030
 Why?
Amniocentesis
2
1991
20
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2015
47
0.030
 Why?
AIDS Dementia Complex
1
2015
52
0.030
 Why?
Analysis of Variance
2
2011
1309
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Depressive Disorder
1
1998
368
0.030
 Why?
Half-Life
2
1992
150
0.030
 Why?
Adrenergic beta-Antagonists
1
1996
225
0.030
 Why?
Cross-Sectional Studies
4
2011
5832
0.030
 Why?
Chi-Square Distribution
2
2013
517
0.030
 Why?
Nausea
1
2015
113
0.030
 Why?
Vomiting
1
2015
132
0.030
 Why?
Area Under Curve
1
2015
334
0.030
 Why?
Bromodeoxyuridine
2
2007
80
0.030
 Why?
Fingolimod Hydrochloride
1
2015
39
0.030
 Why?
Disease Susceptibility
1
1996
352
0.030
 Why?
Gene Regulatory Networks
1
2017
322
0.030
 Why?
Product Surveillance, Postmarketing
1
2015
69
0.030
 Why?
Breast Feeding
1
2018
449
0.030
 Why?
Belgium
1
2014
12
0.030
 Why?
Neutropenia
1
2015
156
0.030
 Why?
Vaccines, Virus-Like Particle
1
2014
5
0.030
 Why?
Headache
1
2015
153
0.030
 Why?
HLA-A2 Antigen
1
2014
47
0.030
 Why?
Metabolic Diseases
1
2015
114
0.030
 Why?
Rubella
1
1974
22
0.030
 Why?
Culture Media
2
1984
160
0.030
 Why?
Immunoblotting
1
1994
307
0.030
 Why?
Tetanus Toxoid
1
1994
34
0.030
 Why?
Probability
2
2005
306
0.030
 Why?
Drugs, Investigational
1
2014
31
0.030
 Why?
Bacterial Proteins
1
2000
943
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
1994
29
0.030
 Why?
Anemia
1
2015
180
0.030
 Why?
Statistics, Nonparametric
2
2004
432
0.020
 Why?
Seroepidemiologic Studies
1
2014
174
0.020
 Why?
Phenotype
1
2002
3202
0.020
 Why?
Thrombocytopenia
1
2015
208
0.020
 Why?
Developed Countries
1
2013
37
0.020
 Why?
Haplorhini
8
1974
52
0.020
 Why?
Mortality
1
2015
364
0.020
 Why?
Drug Tolerance
1
1992
100
0.020
 Why?
Human papillomavirus 6
1
2011
3
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Mycoplasma Infections
1
1991
17
0.020
 Why?
Arthritis, Rheumatoid
1
2021
1171
0.020
 Why?
Genetics, Microbial
3
1971
11
0.020
 Why?
Skin
2
1989
766
0.020
 Why?
Safety
1
1994
354
0.020
 Why?
Genitalia, Female
1
2012
42
0.020
 Why?
gamma-Globulins
1
1991
13
0.020
 Why?
Antibodies, Heterophile
1
1991
13
0.020
 Why?
Epstein-Barr Virus Nuclear Antigens
1
1991
12
0.020
 Why?
Phylogeny
2
2006
1015
0.020
 Why?
Absenteeism
1
2012
52
0.020
 Why?
Adrenal Cortex Hormones
1
2015
501
0.020
 Why?
Adenoviruses, Human
1
1991
27
0.020
 Why?
Metabolomics
1
2017
733
0.020
 Why?
Hospitals, University
1
1991
175
0.020
 Why?
Matched-Pair Analysis
1
2011
37
0.020
 Why?
Bodily Secretions
1
2010
2
0.020
 Why?
Early Detection of Cancer
1
2016
464
0.020
 Why?
North America
1
2012
309
0.020
 Why?
Paramyxoviridae Infections
1
1990
12
0.020
 Why?
Tritium
7
1974
69
0.020
 Why?
Diagnosis, Differential
3
2009
1505
0.020
 Why?
Europe
1
2012
413
0.020
 Why?
Inflammation
2
2017
2911
0.020
 Why?
Schwann Cells
1
1990
33
0.020
 Why?
Chlamydia Infections
1
1991
82
0.020
 Why?
DNA
4
1988
1430
0.020
 Why?
Bacterial Infections
2
2001
249
0.020
 Why?
Antigens
2
1970
349
0.020
 Why?
Rhinovirus
1
1990
57
0.020
 Why?
Antigens, Surface
2
1987
157
0.020
 Why?
Serotyping
2
1988
32
0.020
 Why?
Cell Proliferation
1
2018
2545
0.020
 Why?
Health Planning Guidelines
1
2010
24
0.020
 Why?
Self Administration
1
2010
125
0.020
 Why?
Gene Expression Profiling
1
2017
1829
0.020
 Why?
Hepatitis B Antibodies
1
2009
8
0.020
 Why?
Gestational Age
2
1989
977
0.020
 Why?
Drug Resistance, Neoplasm
1
2015
901
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
In Situ Hybridization
2
2001
320
0.020
 Why?
Contraceptive Devices, Male
1
1989
1
0.020
 Why?
Subacute Sclerosing Panencephalitis
1
1989
6
0.020
 Why?
Spermatocidal Agents
1
1989
7
0.020
 Why?
Ribonucleosides
1
1989
7
0.020
 Why?
Reference Values
1
2011
807
0.020
 Why?
Physical Examination
1
2010
236
0.020
 Why?
Immunohistochemistry
1
1993
1735
0.020
 Why?
Thymidine
4
1980
59
0.020
 Why?
Prenatal Exposure Delayed Effects
1
2016
680
0.020
 Why?
RNA, Antisense
1
1988
18
0.020
 Why?
Reference Standards
1
2009
181
0.020
 Why?
Nasal Mucosa
1
2009
111
0.020
 Why?
Astrocytes
1
1990
223
0.020
 Why?
Virus Cultivation
4
1984
31
0.020
 Why?
Reoviridae
1
1988
37
0.020
 Why?
Mammalian orthoreovirus 3
1
1988
38
0.020
 Why?
Measles
1
1989
46
0.020
 Why?
Hepatitis
1
1988
44
0.020
 Why?
DNA, Recombinant
1
1988
48
0.020
 Why?
Reoviridae Infections
1
1988
54
0.020
 Why?
Disease Progression
1
2016
2884
0.020
 Why?
Cancer Vaccines
1
2009
168
0.020
 Why?
Neoplasms, Experimental
1
1969
172
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1988
157
0.020
 Why?
Fetus
1
1992
803
0.020
 Why?
Health Services Needs and Demand
1
2010
282
0.020
 Why?
Cytopathogenic Effect, Viral
2
1982
16
0.020
 Why?
Microscopy, Electron
3
2001
415
0.020
 Why?
Body Fluids
1
1987
71
0.020
 Why?
Australia
1
2008
288
0.020
 Why?
Noma
1
1986
2
0.020
 Why?
Biliary Atresia
1
1988
148
0.020
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
1
2006
13
0.020
 Why?
Xenodiagnosis
1
2006
2
0.020
 Why?
Telomere
1
2010
286
0.020
 Why?
Apoptosis
1
2015
2455
0.020
 Why?
Valine
1
2007
79
0.020
 Why?
Gastrointestinal Hemorrhage
1
1988
129
0.020
 Why?
Embryo, Mammalian
3
1973
234
0.010
 Why?
Interleukin-4
2
1998
213
0.010
 Why?
Amino Acid Substitution
1
2007
304
0.010
 Why?
RNA, Ribosomal
1
2006
165
0.010
 Why?
Kidney
9
1975
1497
0.010
 Why?
Statistics as Topic
1
2006
280
0.010
 Why?
Reagent Kits, Diagnostic
1
1985
35
0.010
 Why?
Anti-Bacterial Agents
2
1999
1915
0.010
 Why?
Ketones
1
1986
53
0.010
 Why?
Nectins
1
2005
7
0.010
 Why?
Gene Amplification
1
2006
121
0.010
 Why?
Lymphoproliferative Disorders
1
1985
54
0.010
 Why?
Residence Characteristics
1
2008
375
0.010
 Why?
Mass Screening
1
2014
1331
0.010
 Why?
Factor Analysis, Statistical
1
2006
292
0.010
 Why?
Carbon Isotopes
5
1973
143
0.010
 Why?
California
1
2006
469
0.010
 Why?
Streptococcus pneumoniae
1
2006
178
0.010
 Why?
Chromosomes, Human
1
1984
44
0.010
 Why?
Toll-Like Receptor 2
1
2005
126
0.010
 Why?
Cytotoxicity, Immunologic
1
1985
227
0.010
 Why?
Hexuronic Acids
1
1984
23
0.010
 Why?
Glucuronic Acid
1
1984
25
0.010
 Why?
Intensive Care Units, Neonatal
1
1988
277
0.010
 Why?
Toll-Like Receptors
1
2005
195
0.010
 Why?
Alginates
1
1984
49
0.010
 Why?
Freezing
1
1984
86
0.010
 Why?
Filtration
1
1984
70
0.010
 Why?
Polyethylene Glycols
1
1989
646
0.010
 Why?
Culture Techniques
4
1973
67
0.010
 Why?
Bone Marrow Cells
1
1984
322
0.010
 Why?
RNA, Small Interfering
1
2005
646
0.010
 Why?
Fetal Blood
1
1985
340
0.010
 Why?
Stomatitis, Herpetic
1
1982
5
0.010
 Why?
Phosphonoacetic Acid
1
1982
10
0.010
 Why?
Socioeconomic Factors
1
2007
1329
0.010
 Why?
Up-Regulation
1
2005
864
0.010
 Why?
Agammaglobulinemia
1
1982
35
0.010
 Why?
Isoelectric Focusing
1
2001
30
0.010
 Why?
NF-kappa B
1
2005
671
0.010
 Why?
Prognosis
1
2010
4260
0.010
 Why?
Ulnar Nerve
1
2001
17
0.010
 Why?
Rural Population
1
2006
652
0.010
 Why?
Interleukin-6
1
2005
791
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
2001
331
0.010
 Why?
Temperature
1
1984
684
0.010
 Why?
Cell Survival
1
1984
1113
0.010
 Why?
Brain
1
1993
2935
0.010
 Why?
Administration, Oral
2
1997
846
0.010
 Why?
Phytohemagglutinins
1
1980
29
0.010
 Why?
Serum Albumin
1
2001
150
0.010
 Why?
Disease Models, Animal
1
1991
4605
0.010
 Why?
Neuroglia
1
2001
173
0.010
 Why?
Phagocytosis
1
1982
303
0.010
 Why?
Ribosomes
1
2001
194
0.010
 Why?
Cell Communication
1
1982
326
0.010
 Why?
Leukocytes
1
1981
298
0.010
 Why?
Ambulatory Care
1
2004
600
0.010
 Why?
Air Microbiology
1
1980
50
0.010
 Why?
Nasal Decongestants
1
1999
8
0.010
 Why?
Immunity, Maternally-Acquired
1
1979
18
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
41
0.010
 Why?
Immunoglobulins
1
1979
163
0.010
 Why?
Mitogens
1
1978
56
0.010
 Why?
Lectins
1
1978
44
0.010
 Why?
Steroids
1
1999
162
0.010
 Why?
Rabbits
1
1979
658
0.010
 Why?
Th2 Cells
1
1998
183
0.010
 Why?
Amanitins
1
1977
4
0.010
 Why?
Bronchopulmonary Dysplasia
2
1993
414
0.010
 Why?
Cross Infection
1
1980
262
0.010
 Why?
Centrifugation, Density Gradient
3
1971
40
0.010
 Why?
Antigen-Antibody Complex
1
1997
72
0.010
 Why?
Interleukin-10
1
1998
311
0.010
 Why?
Combined Modality Therapy
1
1999
1267
0.010
 Why?
Erythrocytes
1
1982
757
0.010
 Why?
Adenoviridae Infections
1
1975
20
0.010
 Why?
Evidence-Based Medicine
1
1999
714
0.010
 Why?
Indicator Dilution Techniques
1
1994
12
0.010
 Why?
Uridine
2
1973
30
0.010
 Why?
Patient Selection
1
1999
700
0.010
 Why?
Centrifugation, Zonal
2
1971
2
0.010
 Why?
Abortion, Therapeutic
1
1974
3
0.010
 Why?
Rubella virus
1
1974
7
0.010
 Why?
Cesium
2
1971
20
0.010
 Why?
Heart Defects, Congenital
2
1993
898
0.010
 Why?
Molecular Biology
2
1971
61
0.010
 Why?
Sucrose
2
1971
112
0.010
 Why?
Chlorides
2
1971
139
0.010
 Why?
Complement Fixation Tests
2
1984
5
0.010
 Why?
Hemagglutination Tests
1
1991
7
0.010
 Why?
Pulmonary Fibrosis
1
1975
404
0.010
 Why?
Genes
1
1971
226
0.010
 Why?
Population Surveillance
1
1993
491
0.000
 Why?
Stress, Psychological
1
1998
1154
0.000
 Why?
Nonoxynol
1
1989
4
0.000
 Why?
Latex
1
1989
8
0.000
 Why?
Kidney Transplantation
1
1975
704
0.000
 Why?
Suspensions
1
1987
29
0.000
 Why?
Ribonucleases
1
1987
49
0.000
 Why?
Chloroquine
1
1987
54
0.000
 Why?
Deltaretrovirus
1
1986
12
0.000
 Why?
Binding, Competitive
1
1985
192
0.000
 Why?
Leukocyte Count
1
1985
319
0.000
 Why?
Mitosis
1
1985
202
0.000
 Why?
Histocompatibility Antigens Class II
1
1985
366
0.000
 Why?
Serologic Tests
1
1983
53
0.000
 Why?
Histocompatibility Antigens
2
1974
103
0.000
 Why?
Infusions, Parenteral
1
1982
43
0.000
 Why?
Leukemia
1
1983
248
0.000
 Why?
Hospital Bed Capacity, 300 to 499
1
1980
3
0.000
 Why?
Air Movements
1
1980
10
0.000
 Why?
Hospital Units
1
1980
32
0.000
 Why?
Boston
1
1980
93
0.000
 Why?
Liver
1
1988
1856
0.000
 Why?
Communicable Disease Control
1
1980
86
0.000
 Why?
Methods
1
1978
67
0.000
 Why?
p-Fluorophenylalanine
1
1976
2
0.000
 Why?
Cycloheximide
1
1976
47
0.000
 Why?
Hospitals, Pediatric
1
1980
554
0.000
 Why?
Inclusion Bodies, Viral
1
1975
3
0.000
 Why?
Cytoplasm
1
1976
270
0.000
 Why?
Cadaver
1
1975
304
0.000
 Why?
Transplantation, Homologous
1
1975
419
0.000
 Why?
Genetic Code
1
1971
25
0.000
 Why?
Nucleic Acid Denaturation
1
1971
31
0.000
 Why?
Chymotrypsin
1
1971
23
0.000
 Why?
Platinum
1
1971
50
0.000
 Why?
Molecular Weight
1
1971
325
0.000
 Why?
Carbon
1
1971
203
0.000
 Why?
DNA Replication
1
1971
259
0.000
 Why?
Hot Temperature
1
1971
407
0.000
 Why?
Lung
1
1975
4192
0.000
 Why?
Levin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (855) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)